KT109 T27752
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
KT109 is a selective inhibitor of DAGL_ (IC50 = 42 nM). KT109-treated wild-type mice displayed reductions in LPS-induced allodyni as well as in DAGL-_ (-/-) micea. Repeated KT109 administration prevented the expression of LPS-induced allodynia, without ev
CAS nr:
1402612-55-8
Purity:
98%
Molecular Weight:
422,53
SMILES:
O=C(N1N=NC(C2=CC=C(C3=CC=CC=C3)C=C2)=C1)N4C(CC5=CC=CC=C5)CCCC4
Formula:
C27H26N4O
Pathway:
Target:
